C4 Therapeutics Inc
(CCCC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,809 | 78,157 | 51,293 | 55,499 | 59,649 |
| Marketable Securities | 133,075 | 136,397 | 163,794 | 189,405 | 195,992 |
| Receivables | 6,542 | 2,158 | 8,028 | 3,102 | 10,341 |
| TOTAL | $206,864 | $224,729 | $232,535 | $257,767 | $273,228 |
| Non-Current Assets | |||||
| PPE Net | 5,134 | 5,540 | 5,478 | 5,842 | 6,206 |
| Investments And Advances | 7,875 | 8,419 | 19,619 | 22,359 | 28,759 |
| Other Non-Current Assets | 45,615 | 57,839 | 61,892 | 63,634 | 67,867 |
| TOTAL | $58,624 | $71,798 | $86,989 | $91,835 | $102,832 |
| Total Assets | $265,488 | $296,527 | $319,524 | $349,602 | $376,060 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,333 | 2,216 | 683 | 1,328 | 1,504 |
| Accrued Expenses | 11,270 | 13,554 | 12,633 | 19,363 | 15,388 |
| TOTAL | $35,945 | $44,456 | $40,820 | $45,177 | $43,293 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 17,126 | 22,620 | 21,585 | 18,712 | 20,769 |
| Other Non-Current Liabilities | 55,247 | 56,857 | 58,447 | 59,982 | 61,463 |
| TOTAL | $75,135 | $78,007 | $83,564 | $88,439 | $90,111 |
| Total Liabilities | $111,080 | $122,463 | $124,384 | $133,616 | $133,404 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,914 | 71,171 | 71,007 | 70,990 | 70,589 |
| Common Shares | 7 | 7 | 7 | 7 | 7 |
| Retained earnings | -718,207 | -686,041 | -660,021 | -633,699 | -599,126 |
| Other shareholders' equity | 87 | -30 | 43 | 53 | 455 |
| TOTAL | $154,408 | $174,064 | $195,140 | $215,986 | $242,656 |
| Total Liabilities And Equity | $265,488 | $296,527 | $319,524 | $349,602 | $376,060 |